Jeremy P. Springhorn's Net Worth
$172 Thousand
Who is Jeremy P. Springhorn?
Jeremy P. Springhorn does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include uniQure N.V., and Syros Pharmaceuticals, Inc..
SEC CIK
Jeremy P. Springhorn's CIK is 0001717852
Past Insider Trading and Trends
2019 was Jeremy P. Springhorn's most active year for acquiring shares with 6 total transactions. Jeremy P. Springhorn's most active month to acquire stocks was the month of January. 2020 was Jeremy P. Springhorn's most active year for disposing of shares, totalling 2 transactions. Jeremy P. Springhorn's most active month to dispose stocks was the month of December. 2017 saw Jeremy P. Springhorn paying a total of $136,260.00 for 225,000 shares, this is the most they've acquired in one year. In 2020 Jeremy P. Springhorn cashed out on 807 shares for a total of $50,190.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
uniQure N.V. (QURE) Snapshot price: $5.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.01% | 8.08K |
—
|
—
| 31.84K |
Jun 19
| |||
Form 4
| -8.59% | -2.23K |
$5.12 | -$11,422.72 | 23.76K |
Jun 13
| |||
Form 4
| +32.77% | 6.41K |
$18.88 | -$43,159.68 | 25.99K |
Jun 13 - Jun 16
| |||
Form 4
| -1.92% | -384.00 |
$20.41 | -$7,837.44 | 19.57K |
Feb 27
| |||
Form 4
| +83.48% | 9.08K |
—
|
—
| 19.96K |
Jun 15
| |||
Form 4
| -5.24% | -602.00 |
$16.70 | -$10,053.40 | 10.88K |
Feb 28
| |||
Form 4
| +15.42% | 1.53K |
—
|
—
| 11.48K |
Feb 24
| |||
Form 4
| -4.83% | -505.00 |
$37.50 | -$18,937.50 | 9.95K |
Mar 2
| |||
Form 4
| +29.52% | 2.38K |
—
|
—
| 10.45K |
Feb 25
| |||
Form 4
| +34.35% | 2.06K |
—
|
—
| 8.07K |
Feb 27
| |||
Form 4
| -11.85% | -807.00 |
$62.19 | -$50,190.36 | 6K |
Jan 28
| |||
Form 4
| -15.08% | -1.21K |
$31.32 | -$37,897.20 | 6.81K |
Jan 28
| |||
Form 4
| +67.40% | 3.23K |
—
|
—
| 8.02K |
Jan 25
| |||
Form 4
|
∞
| 4.79K |
—
|
—
| 4.79K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +133.33% | 20K |
$4.98 | $99,595.79 | 35K |
Scheduled
|
Nov 11 - Nov 12
| ||
Form 4
| +580.00% | 87K |
—
|
—
| 102K |
Feb 12
| |||
Form 4
|
∞
| 15K |
$9.08 | $136,260.00 | 15K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||